You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

inotuzumab ozogamicin

( IN-oh-TOOZ-ue-mab OH-zoe-ga-MYE-sin )
Funding:
New Drug Funding Program
  • Inotuzumab Ozogamicin - Relapsed or Refractory Acute Lymphoblastic Leukemia
Other Name(s): Besponsa®
Appearance: clear, colourless solution mixed into larger bags of fluids

Patient Info Sheet

Jun 2019

What it is used for

  • For treating a type of blood cancer called ALL (acute lymphoblastic leukemia) in patients who have not responded to previous treatment, or the ALL has come back after previous treatment.


You might also be interested in